+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

LAMEA Drug Testing Market By Drug Type, By Sample Type, By Product Type, By End User, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • ID: 5387642
  • Report
  • June 2021
  • Region: Middle East, Africa
  • 111 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Omega Laboratories, Inc.
  • Quidel Corporation
The Latin America, Middle East and Africa Drug Testing Market is expected to witness market growth of 8% CAGR during the forecast period (2021-2027).

Middle Eastern states and the Islamic world are popular for accepting stringent codes of prohibition. Bans on alcohol consumption in Islamic nations and the prohibition of drug testing at workplaces in specific countries of this region is expected to slow down the growth of the regional market in the next few years. The development of this market is due to the increasing drug & alcohol consumption, the imposition of strict laws necessitating drug & alcohol testing, government investment in key markets of this region. These aspects wherein citizens of various countries of the region are prohibited to use drug is expected to hamper the growth & demand for drug testing in the forthcoming years.

The incidence of drug abuse across the Africa continent is exponentially increasing from cannabis abuse to the more pernicious drugs and from a restricted group of drug users to a broader range of people abusing drugs. Thus, these factors are likely to push the demand for drug testing across this continent in the upcoming years.

One of the major benefits of workplace drug testing is that it helps in creating a safer, better, and healthier workplace environment. Companies are getting more aware of the safety of their employees and hence, they want to ensure a drug-free workplace environment. In addition to it, they also understand the fact that employees under the drug influence pose a major risk to other employees. Therefore, many companies are mandating drug testing so as to ensure the overall wellbeing and health of their employees. Moreover, this is particularly relevant for safety-sensitive jobs such as managing harmful chemicals, working with heavy machines, or driving vehicles for the company. If any of the mentioned activities are performed under the influence of the drug, the possibilities of accidents are significantly increased.

The Brazil market dominated the LAMEA Hospitals Drug Testing Market by Country 2020, thereby, achieving a market value of $23.3 million by 2027. The Argentina market is expected to witness a CAGR of 10.9% during (2021 - 2027). Additionally, The UAE market is expected to witness a CAGR of 9.9% during (2021 - 2027).

Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.

Scope of the Study

Market Segments covered in the Report:

By Drug Type
  • Cannabis/Marijuana
  • Opioids
  • Cocaine
  • Alcohol
  • Amphetamine & Methamphetamine
  • LSD
  • Others
By Sample Type
  • Urine Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples
By Product Type
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
By End User
  • Drug Testing Laboratories
  • Workplaces
  • Hospitals
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Quest Diagnostics, Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Dragerwerk AG & Co. KGaA
  • Quidel Corporation
  • Omega Laboratories, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Omega Laboratories, Inc.
  • Quidel Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Drug Testing Market, by Drug Type
1.4.2 LAMEA Drug Testing Market, by Sample Type
1.4.3 LAMEA Drug Testing Market, by Product Type
1.4.4 LAMEA Drug Testing Market, by End User
1.4.5 LAMEA Drug Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Drug Testing Market by Drug Type
3.1 LAMEA Cannabis/Marijuana Drug Testing Market by Country
3.2 LAMEA Opioids Drug Testing Market by Country
3.3 LAMEA Cocaine Drug Testing Market by Country
3.4 LAMEA Alcohol Drug Testing Market by Country
3.5 LAMEA Amphetamine & Methamphetamine Drug Testing Market by Country
3.6 LAMEA LSD Drug Testing Market by Country
3.7 LAMEA Other Drug Type Drug Testing Market by Country

Chapter 4. LAMEA Drug Testing Market by Sample Type
4.1 LAMEA Drug Testing Urine Samples Market by Country
4.2 LAMEA Drug Testing Oral Fluid Samples Market by Country
4.3 LAMEA Drug Testing Hair Samples Market by Country
4.4 LAMEA Drug Testing Other Samples Market by Country

Chapter 5. LAMEA Drug Testing Market by Product Type
5.1 LAMEA Consumables Drug Testing Market by Country
5.2 LAMEA Instruments Drug Testing Market by Country
5.3 LAMEA Rapid Testing Devices Drug Testing Market by Country
5.4 LAMEA Services Drug Testing Market by Country

Chapter 6. LAMEA Drug Testing Market by End-use
6.1 LAMEA Drug Testing Laboratories Drug Testing Market by Country
6.2 LAMEA Workplaces Drug Testing Market by Country
6.3 LAMEA Hospitals Drug Testing Market by Country
6.4 LAMEA Others Drug Testing Market by Country

Chapter 7. LAMEA Drug Testing Market by Country
7.1 Brazil Drug Testing Market
7.1.1 Brazil Drug Testing Market by Drug Type
7.1.2 Brazil Drug Testing Market by Sample Type
7.1.3 Brazil Drug Testing Market by Product Type
7.1.4 Brazil Drug Testing Market by End-use
7.2 Argentina Drug Testing Market
7.2.1 Argentina Drug Testing Market by Drug Type
7.2.2 Argentina Drug Testing Market by Sample Type
7.2.3 Argentina Drug Testing Market by Product Type
7.2.4 Argentina Drug Testing Market by End-use
7.3 UAE Drug Testing Market
7.3.1 UAE Drug Testing Market by Drug Type
7.3.2 UAE Drug Testing Market by Sample Type
7.3.3 UAE Drug Testing Market by Product Type
7.3.4 UAE Drug Testing Market by End-use
7.4 Saudi Arabia Drug Testing Market
7.4.1 Saudi Arabia Drug Testing Market by Drug Type
7.4.2 Saudi Arabia Drug Testing Market by Sample Type
7.4.3 Saudi Arabia Drug Testing Market by Product Type
7.4.4 Saudi Arabia Drug Testing Market by End-use
7.5 South Africa Drug Testing Market
7.5.1 South Africa Drug Testing Market by Drug Type
7.5.2 South Africa Drug Testing Market by Sample Type
7.5.3 South Africa Drug Testing Market by Product Type
7.5.4 South Africa Drug Testing Market by End-use
7.6 Nigeria Drug Testing Market
7.6.1 Nigeria Drug Testing Market by Drug Type
7.6.2 Nigeria Drug Testing Market by Sample Type
7.6.3 Nigeria Drug Testing Market by Product Type
7.6.4 Nigeria Drug Testing Market by End-use
7.7 Rest of LAMEA Drug Testing Market
7.7.1 Rest of LAMEA Drug Testing Market by Drug Type
7.7.2 Rest of LAMEA Drug Testing Market by Sample Type
7.7.3 Rest of LAMEA Drug Testing Market by Product Type
7.7.4 Rest of LAMEA Drug Testing Market by End-use

Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Siemens AG (Siemens Healthineers)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Dragerwerk AG & Co. KGaA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quidel Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials & Approvals:
8.10. Omega Laboratories, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
8.10.2.2 Accreditation:
Note: Product cover images may vary from those shown
  • Quest Diagnostics, Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Dragerwerk AG & Co. KGaA
  • Quidel Corporation
  • Omega Laboratories, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll